Table 1

Coding myelodysplastic syndrome using ICD-O-3 and ICD-9-CM

MDSAbbreviationICD-O-3ICD-9-CM
Prior to October 2006October 2006 and later
Refractory anemia RA 9980 284.9 238.72 
Refractory anemia with ringed sideroblasts RARS 9982 285.0 238.72 
Refractory anemia with excess blasts* RAEB 9983 285.0 238.73 
Refractory anemia with excess blasts in transformation RAEB-T 9984 285.0 238.73 
Refractory cytopenia with multilineage dysplasia RCMD 9985 238.7 238.72 
Myelodysplastic syndrome with 5q deletion syndrome MDS 5q 9986 238.7 238.74 
Therapy-related myelodysplastic syndrome, NOS t-MDS 9987 238.7 238.72 
Myelodysplastic syndrome, NOS MDS 9989 238.7 238.75 
MDSAbbreviationICD-O-3ICD-9-CM
Prior to October 2006October 2006 and later
Refractory anemia RA 9980 284.9 238.72 
Refractory anemia with ringed sideroblasts RARS 9982 285.0 238.72 
Refractory anemia with excess blasts* RAEB 9983 285.0 238.73 
Refractory anemia with excess blasts in transformation RAEB-T 9984 285.0 238.73 
Refractory cytopenia with multilineage dysplasia RCMD 9985 238.7 238.72 
Myelodysplastic syndrome with 5q deletion syndrome MDS 5q 9986 238.7 238.74 
Therapy-related myelodysplastic syndrome, NOS t-MDS 9987 238.7 238.72 
Myelodysplastic syndrome, NOS MDS 9989 238.7 238.75 
*

In October 2009, RAEB with 5%-9% blasts (RAEB-1) was reclassified from 238.73 to 238.72 to improve coverage of erythropoiesis-stimulating agent treatment for patients with MDS. However, RAEB with 10%-19% (RAEB-2) remained under 238.73.20 

In October 2009, a new code for antineoplastic chemotherapy–induced anemia (285.3) was introduced, but not incorporated within SEER. NOS is listed where a topographic or morphologic term is not modified, has an adjective that does not appear elsewhere, or is used in a general sense.20 

or Create an Account

Close Modal
Close Modal